Moors & Cabot’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-17,833
| Closed | -$1.77M | – | 650 |
|
2019
Q3 | $1.77M | Buy |
17,833
+273
| +2% | +$27.1K | 0.2% | 127 |
|
2019
Q2 | $1.62M | Buy |
17,560
+2,010
| +13% | +$186K | 0.21% | 122 |
|
2019
Q1 | $1.46M | Buy |
15,550
+8,049
| +107% | +$758K | 0.2% | 124 |
|
2018
Q4 | $481K | Sell |
7,501
-1,615
| -18% | -$104K | 0.08% | 259 |
|
2018
Q3 | $813K | Buy |
9,116
+59
| +0.7% | +$5.26K | 0.1% | 223 |
|
2018
Q2 | $725K | Buy |
9,057
+1,665
| +23% | +$133K | 0.1% | 232 |
|
2018
Q1 | $659K | Buy |
7,392
+1,914
| +35% | +$171K | 0.09% | 265 |
|
2017
Q4 | $569K | Buy |
5,478
+1,285
| +31% | +$133K | 0.08% | 291 |
|
2017
Q3 | $611K | Buy |
4,193
+105
| +3% | +$15.3K | 0.09% | 271 |
|
2017
Q2 | $529K | Buy |
4,088
+487
| +14% | +$63K | 0.09% | 275 |
|
2017
Q1 | $447K | Sell |
3,601
-207
| -5% | -$25.7K | 0.08% | 295 |
|
2016
Q4 | $442K | Buy |
3,808
+501
| +15% | +$58.2K | 0.07% | 311 |
|
2016
Q3 | $344K | Sell |
3,307
-475
| -13% | -$49.4K | 0.06% | 343 |
|
2016
Q2 | $377K | Sell |
3,782
-2,595
| -41% | -$259K | 0.07% | 315 |
|
2016
Q1 | $638K | Buy |
6,377
+525
| +9% | +$52.5K | 0.12% | 217 |
|
2015
Q4 | $702K | Sell |
5,852
-1,330
| -19% | -$160K | 0.13% | 203 |
|
2015
Q3 | $780K | Sell |
7,182
-472
| -6% | -$51.3K | 0.14% | 179 |
|
2015
Q2 | $891K | Buy |
7,654
+584
| +8% | +$68K | 0.14% | 172 |
|
2015
Q1 | $822K | Sell |
7,070
-130
| -2% | -$15.1K | 0.14% | 179 |
|
2014
Q4 | $804K | Buy |
7,200
+860
| +14% | +$96K | 0.14% | 176 |
|
2014
Q3 | $598K | Buy |
6,340
+1,350
| +27% | +$127K | 0.1% | 222 |
|
2014
Q2 | $428K | Buy |
+4,990
| New | +$428K | 0.07% | 300 |
|